Covid-19 vaccine could be ready by late June - UK scientists predict

Covid-19 vaccine could be ready by late June - UK scientists predict

- A group of scientists in the UK is working on making a cure to coronavirus available as soon as late June

- Using a process called recovery trial, the medical officials are looking at a combination of drugs that have been effective in making patients recover

- Among the drugs are hydroxychloroquine, lopinavir-ritonavir, and tocilizumab which have been administered to Covid-19 patients

PAY ATTENTION: Click “See First” under the “Following” tab to see News on your Facebook News Feed!

Scientists have predicted that a vaccine for coronavirus could be ready as soon as results of over 10,000 Covid-19 patients who were involved in a clinical trial are ready by late June 2020.

The Sun UK reports that if the experts carrying out the trial process are successful, the vaccine could be rolled out immediately.

According to the same media, the recovery trial is a scientific evaluation that looks at overall Covid-19 therapy and medications that were administered with the hope of getting the combination that is effective in treating patients.

Read also

Finally, solution for COVID-19 in sight? It comes in the form of an inhaler and researchers have started distribution

The deputy chief investigator of the trial at Oxford University, Professor Martin Landray, said they are being meticulous with their process.

A picture showing a scientist working in the lab. Photo source: SafetySkills
A picture showing a scientist working in the lab. Photo source: SafetySkills
Source: UGC

Landry added that a combination of different drugs could be the best way to beat the coronavirus once and for all.

It should be noted that among the drugs that have been tested and that could make the final combination are hydroxychloroquine, lopinavir-ritonavir, and tocilizumab.

Meanwhile, earlier reported that a dedicated team of local researchers was working on a Covid-19 vaccine with a modification process that can be completed within three weeks to combat Sars-Cov-2 virus and go through a human trial in six months.

The team involved in the vaccine development is called Home-grown Esco Aster and they are working with the United States biotechnology company, Vivaldi Biosciences, as they combine proteins from different viruses to find a cure.

The vaccine they are working on is tagged Esco-Aster DeltaCov and was made by putting together antigens from Sars-Cov-2 virus with “backbone” protein from a flu virus.

Read also

WHO gives new directives on use of chloroquine for Covid-19 treatment

PAY ATTENTION: Download our mobile app to enjoy the latest news

Dr Nandini Prabhakar, a senior scientist, has said that the use of the “backbone” will speed up the process of finding a vaccine.

Another thing worthy of note is that when the vaccine is ready, it can be administered into a patient’s body through a nasal spray, the same way the virus gets into the human body.

In other news, a black taxi driver, Trevor Belle, died from coronavirus after a passenger who claimed he had the virus spat on him when they were fighting over £9 (N4,263.55) fare.

The 61-year-old driver died from the illness in April at the Royal London Hospital after battling the virus.

Not more than 20 people were allowed at his funeral in order to follow strict social distancing rule.

Coronavirus: Does the Madagascar cure really work? | Legit TV

Read also

Coronavirus: See the big thing these Nigerian youths did for Lagos govt in fight against Covid-19 (photo)


Online view pixel